Top Markets
#1 MowCat MowCat +367.01%
#2 龙虾 (Lobster) 龙虾 (Lobster) +68.62%
#3 SODAX SODAX +47.33%
#4 Cortex Cortex +33.11%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +20.03%
#7 MANTRA MANTRA +18.18%
#8 Akedo Akedo +17.03%
#9 Magma Finance Magma Finance +16.03%
#10 wojak wojak +15.31%
Coin of the day
MowCat MowCat
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Avalyn Pharma Inc. Common Stock Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc. Common Stock

AVLN
Peringkat dalam Saham #7326
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its... Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
Harga Saham
$36.75
Terakhir disinkronkan: 2026-08-27
Kapitalisasi Pasar
$1.63B
Perubahan (1 hari)
-0.78%
Perubahan (1 tahun)
-
Negara
US
Perdagangan Avalyn Pharma Inc. Common Stock (AVLN)

Kategori

Healthcare
Rasio P/B untuk Avalyn Pharma Inc. Common Stock (AVLN)
Rasio P/B per 2026 TTM: 0
Menurut laporan keuangan dan harga saham terbaru dari Avalyn Pharma Inc. Common Stock, rasio P/B saat ini (TTM) adalah 0. Pada akhir 2026, rasio P/B perusahaan adalah 0.
Riwayat rasio P/B untuk Avalyn Pharma Inc. Common Stock dari 2026 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH